Notice of Intent to Sole Source for Organisms and Drug/Drug Classes of Critical/Serious Concern to Advance Regulatory Science and Public Health
Closed Pre-Solicitation Posted
- Solicitation number
- 75F40120Q00107
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Place of performance
- Silver Spring MD 20993 USA
Notice details come from SAM.gov. Updated .
Notice text
The Food and Drug Administration (FDA), the Office of Acquisitions and Grants Services (OAGS) intends to inform the public that the FDA anticipates issuing an award to procure the development of an unambiguous, comprehensive database/repository model that can allow for mapping and classifying evidence of the relationship between molecular (genotype) mechanism of resistance and phenotypic resistance for clinically relevant human bacterial pathogens. The services needed shall capture existing knowledge about phenotypic resistance and molecular detection, to make the results of an in vitro diagnostic device “actionable” when reporting results in the same manner as current phenotypic antimicrobial susceptibility test methods ; this can only be accomplished by a ‘living’ database, one that FDA, sponsors, and clinicians can use for regulatory and clinical practice. The Period of Performance includes a one-year Base Period.
Files
| File | Type | Posted |
|---|---|---|
| NOI SS 1229137.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity